Lung Cancer Clinical Trial
Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS)
Summary
This randomized controlled trial seeks to evaluate the effectiveness of alternative strategies to integrate smoking cessation interventions into the delivery of low-dose CT (LDCT) lung cancer screening. Using a factorial design, current smokers who enroll will be randomly assigned to receive these interventions: (1) smoking cessation counseling support by telephone or videoconferencing (short duration vs. long duration); (2) nicotine patch treatment (NRT) (short vs.long duration); (3) counselor-facilitated referral (vs. no referral) to an online resource to connect smokers to a community-based social service resources.
Full Description
Evidence-based tobacco dependence treatment consists of behavioral counseling and pharmacotherapy. Nicotine patch is an FDA-approved cessation aid. The optimal duration of counseling and pharmacotherapy for patients undergoing low-dose CT (LDCT) lung screening is not clear. In addition, helping smokers to address other social and psychological barriers might help them succeed in quitting smoking. This randomized controlled trial will test, in a factorial design, two options for delivering each of 3 interventions to help current smokers stop smoking in the context of having routine CT lung cancer screening. Patients will receive 4 or 8 weeks of behavioral counseling (with their choice of video conferencing or regular telephone calls), 2 or 8 weeks of nicotine patch, and will receive referral (vs. no referral) to an online resource to connect smokers to community-based social service resources. Outcome measures for smoking cessation will be assessed by a survey administered by phone at 3,and 6 months.
Eligibility Criteria
Inclusion Criteria:
Scheduled to undergo LDCT-LCS at a participating Mass General Brigham Health Care System LCS site
Speak English or Spanish.
Current smokers: smoked a cigarette, even a puff, in the last 30 days.
Medicare coverage requirement (age 50-80 years, 20+ pack/years).
Residing within the USA.
Exclusion Criteria:
Undergoing lung CT as part of a diagnostic or abnormal follow-up evaluation.
Unable to give informed consent due to psychiatric or cognitive impairment as determined in consultation with study PI or treating clinician.
No access to a telephone or cannot communicate by telephone.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 6 Locations for this study
Boston Massachusetts, 02114, United States More Info
Contact
Boston Massachusetts, 02115, United States More Info
Contact
Boston Massachusetts, 02130, United States More Info
Contact
Newton Massachusetts, 02462, United States More Info
Contact
Oak Bluffs Massachusetts, 02557, United States More Info
Contact
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.